$14.80
-1.57-9.6%
Last update: Nov 10, 10:31 AM
Jasper Therapeutics Inc
JSPRNASDAQ
The average analyst price target for Jasper Therapeutics is $251.67, 1600.6% above the current price. Of 13 analysts, 8 rate it Buy and 5 Hold. Targets range from $45 to $750. The latest change came on Aug 12, 2026, when Piper Sandler initiated coverage of Jasper Therapeutics with an Overweight rating and a $60 price target.
Price Target Range — 11 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
